The bone marrow-derived mesenchymal stem cells (BMSCs) alleviate diabetic peripheral neuropathy induced by STZ via activating GSK-3β/β-catenin signaling pathway
Publication date: Available online 2 June 2020Source: Environmental Toxicology and PharmacologyAuthor(s): Dingwen He, Xu Yanjie, Xiong Xi, Changchang Yin, Shuihong Lei, Xigao Cheng
Source: Environmental Toxicology and Pharmacology - Category: Environmental Health Source Type: research
More News: Brain | Diabetes | Drugs & Pharmacology | Endocrinology | Environmental Health | Neurology | Peripheral Neuropathy | Stem Cell Therapy | Stem Cells | Toxicology